U.S. Injectable Drug Pipeline

U.S. Injectable Drug Pipeline published by Frost & Sullivan in June, 2009. This report consists of 128 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges, drivers, and restraints and identified and discussed as well as hot topics and trends relating to injectable drug development.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

• Introduction

2. MARKET OVERVIEW

Research Scope and Methodology

• Scope and Segmentation
• Research Methodology

Market Introduction

• Introduction
• Hot Topics and Trends
• Patient Willingness to Use Injection Types
• Leading Companies
• Industry Challenges
• Market Drivers
• Market Restraints

3. PIPELINE ANALYSIS

Introduction

• Pipeline Overview

Intramuscular Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

Subcutaneous Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

Intravenous Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

Other Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

4. DECISION SUPPORT DATABASES

Oncology Databases

• Incidence of Colon Rectum Cancer
• Total Cancer Cases
• Incidence of Bladder Cancer
• Incidence of Breast Cancer
• Incidence of Lung Cancer
• Incidence of Stomach Cancer

Autoimmune and Inflammatory Disorders Databases

• Prevalence of Asthma
• Prevalence of Arthritis
• Total Cases of Multiple Sclerosis
• Prevalence of Psoriasis

Cardiovascular Disorders Databases

• Prevalence of Cardiovascular Diseases
• Prevalence of Coronary Heart Disease

Related Reports